Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $26.5 million.

  • Lemaitre Vascular's Free Cash Flow rose 11058.37% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.2 million, marking a year-over-year increase of 9774.27%. This contributed to the annual value of $37.2 million for FY2024, which is 2603.27% up from last year.
  • Lemaitre Vascular's Free Cash Flow amounted to $26.5 million in Q3 2025, which was up 11058.37% from $18.9 million recorded in Q2 2025.
  • Over the past 5 years, Lemaitre Vascular's Free Cash Flow peaked at $26.5 million during Q3 2025, and registered a low of $149000.0 during Q1 2023.
  • Its 5-year average for Free Cash Flow is $9.1 million, with a median of $8.3 million in 2022.
  • As far as peak fluctuations go, Lemaitre Vascular's Free Cash Flow plummeted by 9643.11% in 2023, and later skyrocketed by 238389.26% in 2024.
  • Over the past 5 years, Lemaitre Vascular's Free Cash Flow (Quarter) stood at $4.4 million in 2021, then plummeted by 36.7% to $2.8 million in 2022, then soared by 236.07% to $9.5 million in 2023, then soared by 38.78% to $13.1 million in 2024, then soared by 101.58% to $26.5 million in 2025.
  • Its Free Cash Flow stands at $26.5 million for Q3 2025, versus $18.9 million for Q2 2025 and $7.7 million for Q1 2025.